ICON's Nicole Cowan is interviewed in the latest edition of Clinical OMICs about the new biomarker-driven landscape in clinical trials and the nuances of drug-diagnostics co-development programs.
ICON's Nicole Cowan is interviewed in the latest edition of Clinical OMICs about the new biomarker-driven landscape in clinical trials and the nuances of drug-diagnostics co-development programs.